Australia stops COVID-19 vaccine trials after HIV antibody detection

Australia has suspended one of its four COVID-19 vaccine candidates in its phase 1 clinical trials after it was found that many volunteers in the study were developing antibodies for HIV.

The v451 COVID-19 vaccine candidate was being developed by Australia’s University of Queensland and biotech company CSL before suspension. Though the detection of HIV antibodies suspended further trials of the vaccine, there were no serious cases reported with the 216 participants that participated in the trial.

- Advertisement -

The official announcement from the researchers notes that some participants began fragments of an HIV protein named gp41. After consulting with the Australian government, the researchers decided not to move forward with phase 2 and 3 trials.

Read Also: Amoeba inspires solution to the traveling salesman problem

The v451 vaccine candidate was one of four vaccine candidates that the Australian government had committed to buy. It had even placed an order for 51 million doses of the experimental vaccine. Australian Prime Minister Scott Morrison said that the abandoning of the trial shows the haste and careful proceeding mentality of the Australian researchers.

“What happened today is not a surprise to the Government. We are moving swiftly but not with any undue haste,” he said. He added that the system’s working as it should and Australians are protected, as always. The statement by the University of Queensland mentions that more careful testing in regards to HIV should be established in healthcare during the rollout of the COVID-19 vaccine in Australia.

- Advertisement -

Do you want to publish on Apple News, Google News, and more? Join our writing community, improve your writing skills, and be read by hundreds of thousands around the world!

Source: The Hindu

More from Science – News Landed

+ A new app—the iGenomics—makes pocket size DNA analyzer possible
+ Amoeba inspires solution to the traveling salesman problem

+ You can now share tweets to Snapchat; Instagram coming soon
+ New malware affecting browsers such as Edge, Chrome, and Firefox

Related Stories

Curfews sweep Europe to tackle rising COVID-19 cases

Nine months from the initial lockdowns, Europe grapples with record coronavirus cases. It comes as dozens of more contagious...

Brazil’s researchers claim that the Sinovac vaccine is only 50% efficient

On Tuesday (January 12), researchers from Brazil have found out that China's Sinovac vaccine that is being bought by...

Featured Stories

Sturgill Simpson Stops Struggling

Sturgill Simpson has always seemed to struggle. He would prefer being listened to as opposed to just being heard....

Climate change ultimately caused the demise of Transoxania

Climate change doomed the ancient Transoxania civilization, suggests a new study.  An international team of scientists analyzed sediment samples from...

Arecibo Observatory in Puerto Rico collapses

The Arecibo Observatory in Puerto Rico witnessed the crash of its pathbreaking telescope on late Tuesday morning. One of...

Next Step: Jurassic Park? Scientists digitally reconstruct dinosaur brain

As the blockbuster Jurassic Park/World franchise taught us--despite being extinct for more than 60 million years--"Life finds a way", and there...

A tsunami-like mechanism in mice brains teach us more about migraines

A migraine with aura is a severe headache that accompanies symptoms like dizziness, zigzag line vision, blind spots, tingling...

Joseph R. Biden and Kamala D. Harris elected to the White House

At around 11:25 a.m. on November 7, 2020, after nearly 90 hours since polls first closed throughout the United...

Comment Below

Curfews sweep Europe to tackle rising COVID-19 cases

Nine months from the initial lockdowns, Europe grapples with record coronavirus cases. It comes as dozens of more contagious...

Brazil’s researchers claim that the Sinovac vaccine is only 50% efficient

On Tuesday (January 12), researchers from Brazil have found out that China's Sinovac vaccine that is being bought by...